Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Schedule a COVID vaccine appointment

Schedule a COVID vaccine appointment: call us 8am to 5pm, Monday through Friday, at 267-758-4902.

Rabie M. Shanti, DMD, MD

Oral and Maxillofacial Surgery, Otorhinolaryngology
Rabie M. Shanti, DMD, MD
4.9 with 164 ratings

Sees Older Adolescents (ages 15-18), Adults (18-65), Geriatrics (65+)

Rabie M. Shanti, DMD, MD

Oral and Maxillofacial Surgery, Otorhinolaryngology
4.9 with 164 ratings

Sees Older Adolescents (ages 15-18), Adults (18-65), Geriatrics (65+)

  • Assistant Professor of Oral and Maxillofacial Surgery
  • Assistant Professor of Otorhinolaryngology/Head and Neck Surgery
  • Vice Chair for Inclusion, Diversity, and Equity (Department of Oral and Maxillofacial Surgery)
  • Assistant Professor of Otorhinolaryngology: Head and Neck Surgery
  • Dr. Shanti is a Penn Medicine physician.
Accepting new patients

Meet Dr. Shanti

Dr. Rabie Shanti holds a dual appointment in the Department of Oral and Maxillofacial Surgery at Penn Dental Medicine, and the Department of Otorhinolaryngology/Head and Neck Surgery at Penn Medicine. Dr. Shanti’s clinical expertise includes the evaluation and surgical treatment of tumors of the head and neck, such as, benign tumors of the jaws (e.g., ameloblastoma, myxoma), malignant tumors of the jaws (e.g., osteosarcoma, chondrosarcoma), oral (mouth) cancer, and oropharyngeal (throat) cancer. In addition, Dr. Shanti frequently evaluates and manages advanced inflammatory conditions of the jaws, such as, osteoradionecrosis, and medication related osteonecrosis of the jaw. Dr. Shanti’s clinical practice is also devoted to microvascular reconstructive surgery of the head and neck following oncologic surgery, radiation injury, or trauma. 

In addition to his clinical activities, Dr. Shanti is involved in both clinical and translational research efforts that aim to enhance the efficacy of current treatment paradigms, as well as in the development of innovative treatment strategies for patients with benign and malignant tumors of the head and neck.

Back To Top